Scientific and operational leadership for a portfolio of projects to ensure high quality, innovative and effective support to clinical development projects in China. Provide project leadership for projects in region, and supervise direct reports responsible for project leadership Ensure high quality contribution to development strategies together with the local Chinese team and PK PTRs of the global IPTs Provide/Ensure high quality, timely, efficient, and high standard scientific inputs to trial protocols/data analysis/reports, and regulatory submissions in China Represent the pharmacokinetics discipline and ensure high quality interactions with the Chinese health authority, external investigators, and various internal Novartis TAs Establish and maintain sound working relationships with partners and customers Initiate and support continuous improvement initiatives in global pharmacokinetics and partner functions Recruit, coach and develop talents in pharmacokinetics discipline in China Serve as a member on the global PK leadership team Provide input into the PK budget, and manage resources in China PK group Minimum requirements Minimum of a Ph.D. in Pharmacology, Pharmaceutics, or related disciplines (or equivalent degree/knowledge/expertise). Seven to ten years of experience in pharmacokinetics or biopharmaceutics. Experience in international regulatory affairs including Chinese regulatory affairs, global drug development, project management required. Excellent verbal and written English and Chinese communication skills. Administrative management and team leadership experience desired.

企業介紹:
諾華（Novartis AG）是全球醫藥保健行業的領導者。其核心業務涉及專利藥，非專利藥，眼睛護理，消費者保健和動物保健等領域。諾華公司總部設在瑞士巴塞爾，業務遍及全球140多個國家和地區。 諾華（中國）生物醫學研究有限公司是諾華全球研發組織――諾華生物醫學研究所（NIBR）的第八個研究基地。我們位于中國上海市張江高科技園區，將成為諾華在亞洲的主要研究中心，以及除在歐美的研究中心外的最主要的研究中心。我們的研究和探索開發活動的重點是發現并開發創新療法，用于治療在亞洲遠未達到醫藥需求的疾病。我們與從不同之處在于將專注現代藥物的發現和開發方法的研究。最初階段，研發工作將專注在引起中國地方性癌癥的感染原因。我們還將開展臨床試驗，進行安全性研究，生物標志物和檢測分析，表達譜、生物分析以及轉化醫學的研究。